Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Turn Biotechnologies Sharpens Immunology Focus by Adding Two Cell Therapy Specialists to its Medical Advisory Board
Turn Biotechnologies, a cell rejuvenation company developing novel mRNA medicines for untreatable, age-related conditions, announced […]
Zenshine Pharmaceuticals' ZX-7101A Met the Primary Endpoint of the Phase 2 Study for the Treatment of Acute Uncomplicated Influenza in Adults
On April 1st, 2023, during the First Infection Collaboration Forum of the Chinese National Center […]
Notable launches Patient AI, the world's first use of large language models and GPT to bring personalization at scale to healthcare
Notable, the leading intelligent automation company for healthcare, launched Patient AI, the world’s first use […]
Sherlock Biosciences Appoints Maurice Exner as Chief Scientific Officer
Sherlock Biosciences, a company engineering biology to bring next-generation diagnostics to the point-of-need, today announced that […]
Ginkgo Bioworks and WARF Announce Partnership to Discover Next Generation GD2 CAR T-Cell Therapies
The Wisconsin Alumni Research Foundation (WARF), which has a mission of supporting research at the University […]
Visus Therapeutics Appoints Ophthalmology Industry Expert Jehan Tamboowalla to Senior Vice President of Business Development and Marketing
Visus Therapeutics, a clinical-stage biopharmaceutical company focused on developing multi-targeted ophthalmic therapeutics for the front […]
NHS Progress On Waiting List Despite Busiest Winter On Record
The NHS has continued to progress against its elective recovery plan with the number of […]
Novo Holdings Invests in US$105 Million Series C Funding of Alentis Therapeutics
Novo Holdings A/S, a leading international life sciences investor, today announced it has participated in […]
Agathos Biologics Launches Analytical Services
Agathos Biologics, a leading biotechnology company, is proud to offer advanced analytical testing services for […]
Latham BioPharm Group Expands Offering into Digital Health
Latham BioPharm Group (LBG), part of Sia Partners, is excited to announce the addition of a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more